Analystreport

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) was given a new $6.00 price target on by analysts at Leerink Partners. They now have an "outperform" rating on the stock.

Lexicon Pharmaceuticals, Inc.  (LXRX) 
Last lexicon pharmaceuticals, inc. earnings: 4/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: lexpharma.com/investors